SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies (NYSE:A) today announced a new technique developed by a team of University of California at Davis (UCD) and Agilent scientists that enables rapid, detailed analysis of the composition of a group of bioactive molecules in breast milk.
